ArticleExperimental and therapeutic medicine2025
Sesamin induces cell cycle arrest and upregulation of NKG2D ligands in MG‑63 cells and increases susceptibility to NK cell cytotoxicity.
Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteosarcoma is a common solid malignancy in children and adolescents. Despite a success of standard therapeutic approaches, an effective therapeutic strategy is in a great need for improved outcomes. The aim of the present study was to investigate the anticancer effect of sesamin and its influence on NKG2D ligand expression in human osteosarcoma MG-63 cells and to compare the differences in NK cell elimination efficiency before and after treatment. Cell viability of MG-63 cells treated with serial concentrations of sesamin (0-100 µM) was measured using MTT. Induction of cell cycle arrest was determined with flow cytometry. Flow cytometry and reverse transcription-quantitative PCR were employed to detect the changes of protein and mRNA level of NKG2D ligands before and after treatment with sesamin. NK cell elimination assay was performed to determine the changes in NK cell-mediated cytotoxicity against MG-63 cells treated with sesamin. Sesamin induced G
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.